New insights show growing resistance of Helicobacter pylori to key antibiotics across Europe, and the need for tailored, evidence-based treatment.

A recent study published in The American Journal of Gastroenterology underscores how regional resistance patterns impact treatment success. Meanwhile, data from the Hp-EUReg registry, featured in Helicobacter, provide real-world evidence to help guide when (and how) to treat patients more effectively.

What does this mean for clinical care?

  • Test for antibiotic resistance before treatment when possible;
  • Avoid empirical reuse of previously failed therapies;
  • Follow updated guidelines informed by real-world data.

    Thanks to @HpEU-Reg, clinicians and researchers are better equipped to tackle this public health challenge with precision and care. Read the full articles here:

https://journals.lww.com/ajg/fulltext/2024/04000/effectiveness_of_helicobacter_pylori_treatments.17

https://onlinelibrary.wiley.com/doi/10.1111/hel.13111

Share